Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cells
Authors:
- Caroline Vilas Boas de MeloCMCaroline Vilas Boas de Melo
- Maruf Ahmed BhuiyanMBMaruf Ahmed Bhuiyan
- Winfred Nyoroka GatuaWGWinfred Nyoroka Gatua
- Stephen KanyereziSKStephen Kanyerezi
- Leonard UzairueLeonard Uzairue
- Priscilla AbechiPAPriscilla Abechi
- Karan KumarKaran Kumar
- Jabale RahmatJRJabale Rahmat
- Abdulazeez GiwaAGAbdulazeez Giwa
- Gracious MwandiraGMGracious Mwandira
- Abisogun Mujib OlamilekanAOAbisogun Mujib Olamilekan
- Tiffany Ezinne GeorgeTGTiffany Ezinne George
Preprint
Abstract
Introduction: Over 24 million people have been infected globally with the novel coronavirus, SARS-CoV-2, with more than 820,000 succumbing to the resulting COVID-19 disease as of the end of August 2020. The molecular mechanisms underlying the pathogenesis of the disease are not completely elucidated. Thus, we aim to understand host response to SARS-CoV-2 infection by comparing samples collected from two distinct compartments (infection site and blood), obtained from COVID-19 subjects and healthy controls. Methods: We used two publicly available gene expression datasets generated via RNA sequencing in two different samples; nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs). We performed a differential gene expression analysis between COVID-19 subjects and healthy controls in the two datasets and then functionally profiled their differentially expressed genes (DEGs). The genes involved in innate immunity were also determined. Results: We found a clear difference in the host response to SARS-CoV-2 infection between the two sample groups. In COVID-19 subjects, the nasopharyngeal sample group indicated upregulation of genes involved in cytokine activity and interferon signalling pathway, as well as downregulation of genes involved in oxidative phosphorylation and viral transcription. Host response in COVID-19 subjects for the PBMC group, involved upregulation of genes involved in the complement system and immunoglobulin mediated immune response. CXCL13, GABRE, IFITM3 were upregulated and HSPA1B was downregulated in COVID-19 subjects in both sample groups. Conclusion: Our results indicate the host response to SARS-CoV-2 is compartmentalized and suggests potential biomarkers of response to SARS-CoV-2 infection. Highlights: Transcriptomic profiling from publicly available RNA-seq count data revealed a site-specific immune response in COVID-19. Host response was found cellular-mediated in nasopharyngeal samples and humoral-mediated in PBMCs samples. CXCL13, GABRE and IFITM3 commonly upregulated and HSPA1B downregulated in both sample groups highlights the potential of these molecules as markers of response to SARS-CoV-2 infection.Keywords
This publication has 36 references indexed in Scilit:
- Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patientsProtein & Cell, 2020
- Antiviral activities of type I interferons to SARS-CoV-2 infectionAntiviral Research, 2020
- Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1–April 16, 2020JAMA, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19Journal of Medical Virology, 2020
- Heat shock proteins in the physiology and pathophysiology of epidermal keratinocytesCell Stress and Chaperones, 2019
- CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitisBrain, Behavior, and Immunity, 2016
- The host immune response in respiratory virus infection: balancing virus clearance and immunopathologySeminars in Immunopathology, 2016
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected MiceCell Host & Microbe, 2016